“Trans” Activists Write UN Guidelines on “Trans” Care

By | July 14, 2023

NEW YORK, July 14 (C-Fam) The World Health Organization is preparing its first ever global guideline on “transgender” medical protocols to fight the rapid spread of bans and restrictions on “transgender” surgeries and drugs, especially for children.

The WHO guidelines will be geared toward “increasing access and utilization of quality and respectful health services by trans and gender diverse people.” They will promote “gender-affirming care”, “health workers education and training” as well as “legal recognition of self-determined gender identity.”

“Transgender” medical protocols—a recent and experimental area of medical practice—has come under scrutiny across the world in recent months.

Countries that were once pioneers and leaders in administering “transgender” medical protocols are now prohibiting or restricting “transgender” affirming treatments, especially for minors. These include the Netherlands, the United Kingdom, Finland, Sweden, Norway, and Germany, among others. Over a dozen U.S. states have also adopted bans on “trans” care for kids.

The WHO guidelines are expected to take these developments head on. The “guideline development group” chosen by the WHO staff is comprised entirely of “transgender” activists and medical providers. All 14 members of the group are already invested in expanding access to multi-billion dollar “transgender” medical protocols, including for minor children.

Two members from South Africa, Chris McLahlan, a psychologist specializing in “transgender-affirming care,” and Elma de Vries, a family physician, are co-authors of the World Professional Association for Transgender Health’s (WPATH)’ guidelines for transgender health which advocate that children as young as 12 can consent to “transgender” hormone treatment and surgeries and that children even younger than that should be encouraged to “socially transition.”

Another member is Cianán Russell, the Senior Policy Officer at ILGA-Europe, the leading homosexual/transgender advocacy organization in Europe also known for refusing to   condemn adult-child sex. Another, Ayouba El Hamri, is described as “a trans and feminist activist based in Morocco” with several affiliations to “transgender” advocacy groups.

Others include an activist from Lebanon who works in “trans and queer feminist organizing,” an “empowered transgender woman” from the Philippines, a Columbia University professor at the forefront of transgender advocacy, and other transgender advocacy personalities.

The WHO guidelines will have to contend with the growing body of evidence against the efficacy of “transgender” care and about its harms.

There is a well-documented increased risk of suicide for “transgender” identifying individuals after their medical transition, a higher risk than for individuals who identify as “transgender” and never transition. It is increasingly reported that children have adopted “transgender identities under social pressure or anxiety. Moreover, most children who experience discomfort with their biological sex eventually grow out of it. Perhaps, most alarmingly, the life-long consequences of transgender medical protocols are only just becoming widely known.

When children are put on “trans” drug regimens, they may not be aware of, or capable of understanding, the dire consequences of such drugs, including blood clots, cancer, aggressive and premature osteoporosis, infertility, and sexual impotence. Once children are on such drugs, they will likely be required to take medication for the rest of their lives.

The WHO guidelines will not be binding and will not carry any normative weight, but they may prove influential in the long run as professional associations and medical governing bodies may look to them as examples of best practices.

Share on Facebook
Share on Twitter